OrthoPediatrics corp [KIDS] stock is trading at $17.76, down -1.11%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The KIDS shares have gain 2.78% over the last week, with a monthly amount drifted -1.00%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
OrthoPediatrics corp [NASDAQ: KIDS] stock has seen the most recent analyst activity on December 10, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $24. Previously, Lake Street started tracking the stock with Buy rating on April 07, 2025, and set its price target to $37. On January 25, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $31 on the stock. Needham reiterated its Buy rating and increased its price target to $77 on June 14, 2021. Needham reiterated its recommendation of a Buy and reduced its price target to $46 on April 02, 2020. SunTrust started tracking with a Buy rating for this stock on January 08, 2020, and assigned it a price target of $54. In a note dated June 19, 2019, Needham initiated an Buy rating and provided a target price of $53 on this stock.
OrthoPediatrics corp [KIDS] stock has fluctuated between $15.28 and $27.60 over the past year. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. OrthoPediatrics corp [NASDAQ: KIDS] shares were valued at $17.76 at the most recent close of the market. An investor can expect a potential return of 35.14% based on the average KIDS price forecast.
Analyzing the KIDS fundamentals
OrthoPediatrics corp [NASDAQ:KIDS] reported sales of 227.41M for the trailing twelve months, which represents a growth of 12.23%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -0.18%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.13 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.64 points at the first support level, and at 17.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.95, and for the 2nd resistance point, it is at 18.14.
Ratios To Look Out For
For context, OrthoPediatrics corp’s Current Ratio is 7.40. Further, the Quick Ratio stands at 3.52, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 1.96, the price to book ratio is 1.28.
Transactions by insiders
Recent insider trading involved Hite Fred, COO and CFO, that happened on Aug 21 ’25 when 5076.0 shares were purchased. General Counsel and Secretary, Gerritzen Daniel J completed a deal on Mar 18 ’25 to sell 5310.0 shares. Meanwhile, President and CEO Bailey David R sold 6620.0 shares on Mar 18 ’25.
